Quest Diagnostics Incorporated Stock Performance
| DGX Stock | USD 168.77 0.05 0.03% |
Quest Diagnostics has a performance score of 4 on a scale of 0 to 100. The company holds a Beta of 0.39, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Quest Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Quest Diagnostics is expected to be smaller as well. Quest Diagnostics right now holds a risk of 1.32%. Please check Quest Diagnostics standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if Quest Diagnostics will be following its historical price patterns.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Quest Diagnostics Incorporated are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong technical and fundamental indicators, Quest Diagnostics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return 0.0296 | Five Day Return 3.77 | Year To Date Return 11.8 | Ten Year Return 135.22 | All Time Return 4.7 K |
Forward Dividend Yield 0.019 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 3.2 | Dividend Date 2025-04-21 |
1 | Disposition of 35146 shares by Michael Prevoznik of Quest Diagnostics at 86.63 subject to Rule 16b-3 | 11/29/2024 |
2 | Heres Why You Should Retain BDX Stock in Your Portfolio for Now | 01/07/2025 |
3 | Quest Diagnostics Insights on Short Interest Trends | 01/21/2025 |
| Quest Diagnostics dividend paid on 29th of January 2025 | 01/29/2025 |
4 | Quest Diagnostics Inc Recognized as One of Fortunes Worlds Most Admired Companies for 2025 | 01/30/2025 |
5 | Q4 2024 Quest Diagnostics Inc Earnings Call Transcript | 01/31/2025 |
6 | From College to Career - Experiencing the Building Blocks of Professional Success | 02/03/2025 |
7 | Why Quest Diagnostics is a Top Value Stock for the Long-Term | 02/04/2025 |
8 | How Is Quest Diagnostics Expanding Its Role in Healthcare Testing | 02/05/2025 |
9 | PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8 | 02/07/2025 |
10 | Acquisition by Vicky Gregg of tradable shares of Quest Diagnostics at 149.371 subject to Rule 16b-3 | 02/10/2025 |
11 | WCM Investment Management LLC Boosts Stake in Quest Diagnostics Incorporated | 02/11/2025 |
12 | Why Grail Stock Is Jumping Today | 02/12/2025 |
13 | Quest Diagnostics Inc Celebrates 40 Years of Service by Dedicated Employee | 02/13/2025 |
14 | Avestar Capital LLC Cuts Stock Position in Quest Diagnostics Incorporated | 02/14/2025 |
| Begin Period Cash Flow | 686 M |
Quest |
Quest Diagnostics Relative Risk vs. Return Landscape
If you would invest 16,132 in Quest Diagnostics Incorporated on November 18, 2024 and sell it today you would earn a total of 745.00 from holding Quest Diagnostics Incorporated or generate 4.62% return on investment over 90 days. Quest Diagnostics Incorporated is generating 0.0825% of daily returns assuming volatility of 1.3186% on return distribution over 90 days investment horizon. In other words, 11% of stocks are less volatile than Quest, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Quest Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Quest Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Quest Diagnostics Incorporated, and traders can use it to determine the average amount a Quest Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0626
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | DGX | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.32 actual daily | 11 89% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Quest Diagnostics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Quest Diagnostics by adding it to a well-diversified portfolio.
Quest Diagnostics Fundamentals Growth
Quest Stock prices reflect investors' perceptions of the future prospects and financial health of Quest Diagnostics, and Quest Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Quest Stock performance.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0587 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 25.04 B | ||||
| Shares Outstanding | 110.61 M | ||||
| Price To Earning | 14.57 X | ||||
| Price To Book | 2.75 X | ||||
| Price To Sales | 1.89 X | ||||
| Revenue | 9.87 B | ||||
| Gross Profit | 3.27 B | ||||
| EBITDA | 1.35 B | ||||
| Net Income | 921 M | ||||
| Cash And Equivalents | 315 M | ||||
| Cash Per Share | 6.15 X | ||||
| Total Debt | 6.92 B | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 1.46 X | ||||
| Book Value Per Share | 61.06 X | ||||
| Cash Flow From Operations | 1.33 B | ||||
| Earnings Per Share | 7.70 X | ||||
| Market Capitalization | 18.67 B | ||||
| Total Asset | 16.15 B | ||||
| Retained Earnings | 9.36 B | ||||
| Working Capital | 557 M | ||||
| Current Asset | 1.5 B | ||||
| Current Liabilities | 1.17 B | ||||
About Quest Diagnostics Performance
Evaluating Quest Diagnostics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Quest Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Quest Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 10.40 | 10.25 | |
| Return On Tangible Assets | 0.16 | 0.14 | |
| Return On Capital Employed | 0.10 | 0.10 | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 0.13 | 0.08 |
Things to note about Quest Diagnostics performance evaluation
Checking the ongoing alerts about Quest Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Quest Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 93.0% of the company shares are held by institutions such as insurance companies | |
| On 29th of January 2025 Quest Diagnostics paid $ 0.75 per share dividend to its current shareholders | |
| Latest headline from thelincolnianonline.com: Avestar Capital LLC Cuts Stock Position in Quest Diagnostics Incorporated |
- Analyzing Quest Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Quest Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Quest Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Quest Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Quest Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Quest Diagnostics' stock. These opinions can provide insight into Quest Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.